[CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D014747:Vinblastine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D001761:Bleomycin; D014750:Vincristine; D014747:Vinblastine; D008130:Lomustine
Tratamiento de los linfomas resistentes a la quimioterapia con la asociación CCNU-bleomicina-vincristina (vinblastina).